Healthcare Goes Digital Repurposing Off-Patent Drugs Through Crowd Funding with Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures
Jan 12, 2023
Savva Kerdemelidis, legal consultant and entrepreneur who founded Crowd Funded Cures to finance repurposing of off-patent drugs. He discusses interventional pharmacoeconomics and pay-for-success contracts. He explains targeting payers and employers to fund trials. He covers blockchain and IP NFTs for funding and data integrity.
AI Snips
Chapters
Transcript
Episode notes
Why Off‑Patent Drugs Get Ignored
- Off-patent drugs often lack private incentives for repurposing because they can't support monopoly pricing.
- Savva Kerdemelidis proposes contractual and clinical-trial design innovations to create a business model for that research.
Fund Trials From The Cost Savings
- Interventional pharmacoeconomics funds trials by capturing cost savings from using shorter courses or cheaper therapies.
- Those savings can finance trials and scale into larger studies that change standard care.
Pitch Payers To Let You Manage Patients
- Act as an intermediary and offer to manage patient populations to payers by recruiting them into interventional trials.
- Use trial recruitment and cost differentials to immediately save payer money and build evidence.